AMCS Acquires Qv21 Technologies, Strengthening Its Transportation Management Capabilities
4.9.2024 16:00:00 EEST | Business Wire | Press release
AMCS, a global leader of sustainability software for foundational industries, announced today its acquisition of Qv21 Technologies, a leading provider of fleet management and logistics SaaS solutions for short-haul, bulk commodity transportation, for an undisclosed amount.
Founded in 2009 in Austin, Texas, Qv21 Technologies enables short-haul and bulk commodity trucking companies of all sizes to increase operational visibility and improve overall efficiency. With their mission of enabling Logistics Without Barriers™, Qv21’s powerful solution, The LogisticsFramework™ (TLF), streamlines business processes from order to invoice. Backed with robust data management, workflow automation, and analytics capabilities, Qv21 ensures organizations are in complete control of their operations while boosting their savings and profit margins.
The innovative fleet management and logistics solutions by Qv21 Technologies, along with its North American footprint and focus on bulk material transportation, are highly complementary to the AMCS Platform, benefiting customers of both organizations. The acquisition empowers AMCS to expand the capabilities of the AMCS Platform, enabling resource-intensive industries to achieve their sustainability goals faster, more efficiently, and profitably.
“Qv21 Technologies has consistently offered innovative solutions built for short-haul, bulk commodity transportation companies, enhancing operational excellence for leading organizations, including those in the waste and recycling sectors,” said Jonathan Currie, CEO, Qv21 Technologies. “Qv21's commitment to 'Logistics Without Barriers' boosts efficiency and profitability for transporters. Beyond the opportunities for business expansion, our partnership with AMCS further strengthens this pursuit of operational excellence for our clients and accelerates our collective vision for greater sustainability.“
This acquisition paves the way for several synergistic opportunities to be realized, specifically aiding organizations in the long-haul transport of bulk commodities that can support a more circular economy vision. Materials that were previously considered waste and destined for landfill sites can now be effectively directed towards reuse or recycling facilities. With Qv21, AMCS can provide organizations with a solution for a more structured, efficient approach to resource utilization and improved waste management, translating to meaningful progress toward their sustainability goals.
“The strategic addition of Qv21 Technologies signifies a crucial advancement for AMCS, reinforcing our position at the forefront of Performance Sustainability,” explained, Jimmy Martin, co-founder and CEO, AMCS. “This partnership provides tremendous opportunities, specifically for companies engaged within bulk material transportation, to reach their sustainability goals faster. The features that Qv21 brings to the table serve to enhance our capabilities at AMCS, strengthening our ability to support our clients' drive towards enhanced resource management, greater efficiency, sustainability, growth, and profitability.”
AMCS’ Performance Sustainability Suite is the operating system for foundational industries that makes sustainability and profitability possible. The suite manages the running of day-to-day operations such as contracts and pricing, logistics and transportation, materials and resources, health and safety, and sustainability intelligence. The AMCS Performance Sustainability Suite drives growth and profitability, optimizes efficiency and safety, powers corporate sustainability initiatives, and prepares businesses for the circular economy and the future. With AMCS, businesses can improve performance and scale more easily, enabling foundational industry professionals to leave the planet in a better way than they found it.
About Qv21 Technologies
Founded in 2009, Qv21 Technologies is an industry-leading SaaS company specializing in Transportation Management Systems for short-haul, bulk commodity transport. Dedicated to building cloud-based tools, Qv21 supports transporters, carriers, and commodity buyers in navigating industry challenges.
Qv21 Technologies’ flagship solution, The LogisticsFramework™ (TLF), increases operational visibility and streamlines business processes, from order to invoice. As a committed technology provider to trucking companies of all sizes, Qv21 makes increasing savings and profit margins achievable, restoring control of operations back to the organization. Learn more at www.qv21.com
About AMCS
At AMCS we are focused on Performance Sustainability – enabling resource-intensive industries to boost sustainability and profitability. Built on decades of experience, our purpose-built software solutions are designed by people who understand your business, providing practical solutions for the resources, waste, recycling, transportation, manufacturing, and utilities industries.
Headquartered in Ireland, and with offices in Europe, the USA, and Australia, AMCS is a global market leader with over 1,300 mission-driven team members. The combined expertise of our team allows AMCS to deliver innovative solutions and extensive insight, helping customers to drive growth and achieve lasting success. As a trusted global partner, we work with 3800 customers in more than 80 countries delivering digital solutions that create meaningful and measurable impact by increasing customer satisfaction, enhancing sustainability, and boosting margins.
At AMCS, we're ready to innovate with you - deploying our experts, processes, and technology to drive your business forward and prepare you for success in a more sustainable, net zero carbon future. Learn more at: www.amcsgroup.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240904279752/en/
Contacts
Media
Dwayne Weppler
AMCS Group
dwayne.weppler@amcsgroup.com
226 581 5166
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 17:13:00 EEST | Press release
For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and more practical: what it takes to make a specific, high-stakes determination reliable, fast and affordable at scale. A vertical, domain-focused process, gro
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 17:08:00 EEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 17:00:00 EEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by market capitalization and is home to world-leading companies such as Samsung Electr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom